
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
connexin 62 CRISPR/Cas9 KO Plasmid (h) | sc-405882 | 20 µg | $397.00 |
GJA10 encodes connexin 62, a gap junction channel subunit that assembles into connexons to enable direct intercellular exchange of ions and small metabolites. Connexin-mediated coupling supports electrical and metabolic synchronization, contributing to processes such as tissue homeostasis, cell-cycle coordination, and responses to cellular stress through regulated junctional permeability. Altered connexin expression or channel gating is widely linked to disrupted cell–cell communication, with downstream effects on differentiation programs and signaling networks including calcium dynamics and kinase-dependent pathways. As a member of the connexin family, connexin 62 provides a target for investigating how gap junction remodeling influences disease-relevant phenotypes in human cells.
connexin 62 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the GJA10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the GJA10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the GJA10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish connexin 62 protein expression.
This CRISPR knockout system enables efficient generation of GJA10-deficient cell models for investigation of connexin 62 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.